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Background: Optical coherence tomography (OCT) is an intravascular, high-resolution 
imaging technique that is used to characterize atherosclerotic plaques. However, the identifica-
tion of macrophages as important markers of inflammation and plaque vulnerability remains 
difficult. Here, we investigate whether the uptake of very small iron oxide particles (VSOP) 
in macrophages, that cluster in phagolysosomes and allow high-quality magnetic resonance 
imaging (MRI) of atherosclerotic plaques, and uptake of ferumoxytol nanoparticles enhance 
detection of macrophages by OCT.
Materials and methods: RAW 264.7 macrophage cells were incubated with VSOP (1 and 
2 mM Fe) that have been clinically tested and ferumoxytol (8.9 mM Fe) that is approved for 
iron deficiency treatment and currently investigated as an MRI contrast agent. The light scat-
tering of control macrophages, nanoparticle-labeled macrophages (2,000,000 in 500 µL) and 
nanoparticle suspensions was measured in synchronous wavelength scan mode using a fluores-
cence spectrophotometer. For OCT analyses, pellets of 8,000,000 non-labeled, VSOP-labeled 
and ferumoxytol-labeled RAW 264.7 macrophages were imaged and analyzed on an OPTIS™ 
OCT imaging system.
Results: Incubation with 1 and 2 mM VSOP resulted in uptake of 7.1±1.5 and 12±1.5 pg Fe 
per cell, which increased the backscattering of the macrophages in spectrophotometry 2.5- and 
3.6-fold, whereas incubation with 8.9 mM Fe ferumoxytol resulted in uptake of 6.6±2 pg Fe 
per cell, which increased the backscattering 1.5-fold at 700 nm. In contrast, backscattering of 
non-clustered nanoparticles in suspension was negligible. Accordingly, OCT imaging could 
visualize significantly increased backscattering and signal attenuation of nanoparticle-labeled 
macrophages in comparison with controls.
Conclusion: We conclude that VSOP and, to a lesser extent, ferumoxytol increase light scat-
tering and attenuation when taken up by macrophages and can serve as a multimodal imaging 
probe for MRI and OCT to improve macrophage detection in atherosclerotic plaques by OCT 
in the future.
Keywords: intravascular, inflammation, vulnerability, multimodal imaging, optical coherence 
tomography, magnetic resonance imaging
Introduction
Optical coherence tomography (OCT) has become a core intravascular imaging 
modality in clinical practice. The extraordinary high-image resolution allows to 
discriminate several important characteristics of atherosclerotic plaques that are 
associated with severe acute cardiovascular events such as myocardial infarction and 
stroke. Although many important features of plaques can be distinguished by OCT, 
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the assessment of inflammation, for example, by imaging of 
macrophages within the plaque, is still challenging.1,2
Several superparamagnetic iron oxide nanoparticles 
(NPs) that serve as contrast agents for magnetic resonance 
imaging (MRI) have shown accumulation in plaque mac-
rophages. Macrophages are an important indicator for the 
inflammatory activity and vulnerability of atherosclerotic 
lesions. One disadvantage of most sterically stabilized NPs 
is their slow target accumulation of 24 hours and longer. For 
example, ferumoxytol (Feraheme®; AMAG Pharmaceuticals, 
Inc., Waltham, MA, USA), which is clinically approved 
for iron replacement therapy, needs 2 days for substantial 
accumulation in atherosclerotic plaques, as required for 
good contrast in MRI, and peaks after 3 days.3 In contrast, 
electrostatically stabilized citrate-coated very small iron 
oxide particles (VSOP) that were already in clinical testing 
for magnetic resonance (MR) angiography4,5 accumulate 
initially in endothelial cells6 and later in the macrophages of 
atherosclerotic plaques.7 Thus, VSOP allow MR angiography 
and MRI of plaque inflammation in ,3 hours.
Interestingly, transmission electron microscopy (TEM) 
revealed that the uptake of VSOP into the atherosclerotic 
plaques leads to the formation of large NP aggregates in the 
phagolysosomes of endothelial cells and macrophages.7 This 
let us hypothesize that these distribution patterns could cause 
sufficient light scattering to be visualized by OCT.
Consequently, we incubated a macrophage cell line with 
VSOP or ferumoxytol NPs, measured changes of the light 
backscattering signal in suspension by spectrophotometry, 
and compared the OCT signals of cell pellets with the OCT 
signals of NPs in suspension.
Materials and methods
TeM
TEM imaging of VSOP accumulated in macrophages of 
atherosclerotic plaques was done as described elsewhere.7 
The animal experiments were approved by the local animal 
welfare committee (LAGeSo Berlin; license G0168/09) and 
were done in accordance with the “Tierschutz-Versuchstierv
erordnung” of the Federal Ministry of Justice and Consumer 
Protection. In brief, starting at the age of 8 weeks, male 
apoE-/- mice (Taconic, Lille Skensved, Denmark) were fed 
with a Western diet (0.21% cholesterol and 21% fat from lard; 
Altromin) for a duration of 16 weeks. After that, VSOP were 
applied intravenously (500 µmol Fe/kg body weight). Three 
hours after administration, the mice were anesthetized using 
isoflurane and perfused with 20 mL cacodylate buffer (0.1 M; 
pH 7.2) to remove all the blood for subsequent tissue fixation 
with 20 mL of 2.5% glutaraldehyde in cacodylate buffer. 
Heart, aorta and descending vessels were dissected and placed 
in 2.5% glutaraldehyde in cacodylate buffer at 4°C for further 
fixation. Samples were dehydrated in ethanol and embedded in 
Epon embedding media (Serva) and cut in ultra-thin sections 
(70 nm). The sections were analyzed unstained on a Zeiss 
EM906 scanner (Carl Zeiss Meditec AG, Jena, Germany).
cell culture and NP labeling
The macrophage cell line RAW 264.7 was purchased from 
ATCC Cell biology Collection (Promochem LGC, Molsheim, 
France). This cell line is derived from mice peritoneal mac-
rophages transformed by Abelson Murine Leukemia Virus. 
Cells were cultured in DMEM (ATCC) supplemented with 
10% FBS (Thermo Fisher Scientific, Waltham, MA, USA) 
and 1% penicillin–streptomycin (penicillin 10,000 units/mL 
and streptomycin 10 mg/mL; Sigma-Aldrich Co., St Louis, 
MO, USA) and incubated at 37°C in a 5% carbon dioxide 
humidified atmosphere. Cells were regularly passaged until 
they reached around 80% confluence, and the medium was 
changed every 2 days.
For NP uptake, macrophages were cultured (100,000 
cells/cm2 in 75 cm2 tissue culture flasks) overnight to allow 
cell synchronization. On the following day, growth medium 
was removed and cells were gently washed with PBS before 
adding the NP solution in DMEM (ATCC) without phenol 
red supplemented with 1% FBS (Thermo Fisher Scientific). 
Cells were incubated with VSOP (1 mM and 2 mM Fe final 
concentration) or ferumoxytol (Feraheme; 8.9 mM Fe) for 
24 hours at 37°C in a 5% carbon dioxide humidified atmo-
sphere. Non-bound NPs were removed by washing three 
times with PBS, followed by centrifugation of the cells 
(1,000 rpm for 5 minutes) and passage into a 25 cm2 cell 
culture flasks at 100,000 cells/cm2. Overnight cell recovery 
and further internalization of NPs were allowed under cell 
growth conditions before cell pellet collection.
cell phantoms for OcT measurements
For OCT acquisition, the test samples were centrifuged in 
0.2 mL transparent thin-walled polypropylene PCR tubes 
(Thermo Fisher Scientific). These samples contained 8×106 
macrophages (RAW 264.7) equivalent to a volume of 10 µL. 
They were grouped as follows: 1) non-labeled cells used as 
control; 2) cells incubated with VSOP at 1 mM Fe; 3) cells 
incubated with VSOP at 2 mM Fe and 4) cells incubated with 
ferumoxytol at 8.9 mM Fe.
To study the effect of NP aggregation inside the cells 
on optical backscattering and attenuation, two additional 
control samples containing high concentrated stock solu-
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comparison: 5) VSOP 0.5 M Fe in suspension (10 µL) and 
6) ferumoxytol 0.54 M Fe in suspension (10 µL).
cell suspensions for light scattering 
measurements
For light spectroscopy measurements, RAW 264.7 mac-
rophages were incubated with 1 mM Fe, 2 mM VSOP and 8.9 
mM ferumoxytol as previously described. Cell suspensions 
contained 2×106 cells in 500 µL PBS pH 7.4. The cell-free 
NP suspensions were prepared in water at 1 mM Fe for both 
VSOP and ferumoxytol.
Iron quantification
Fractions of cells (n=4 with 50,000 in each) that were used for 
OCT measurements were measured for their NP uptake using 
the colorimetric phenanthroline iron quantification method.8 
The method was adapted for cell pellets stored at -20°C. Cell 
pellets were disrupted by 1 hour ultrasound exposure and the 
incorporated iron was dissolved by adding 5 µL of concentrated 
HCl. Dissolved iron in HCl was diluted in water (1:50) and 
treated at a ratio 2:7:1 with phenanthroline and hydroxylam-
ine hydrochloride for 15 minutes at room temperature. The 
extinctions of the colorimetric reactions of the samples and 
of iron standards were measured photometrically at 510 nm 
and a linear standard curve fit was used to determine the iron 
concentrations. The iron concentrations were divided by the 
cell numbers to calculate the NP uptake per cell (pg Fe/cell).
light spectroscopy measurements
The scattering light intensities of control macrophages, NP-
labeled macrophages and NP suspensions were measured as 
wavelength scan (synchronous scan mode) using an F-7000 
fluorescence spectrophotometer (Hitachi Ltd, Tokyo, Japan). 
With this method, the excitation wavelength is equal to 
the emission wavelength. The scattered light intensity was 
measured according to the manufacturer’s instructions for 
the complete wavelength range of the device (200–900 nm, 
240 nm/min, excitation slit 5.0 nm, emission slit 5.0 nm, 
photomultiplier voltage 400 V, response 2 ms).
The light absorption measurements of VSOP and feru-
moxytol were done using a Specord® 205 Spectrophotometer 
(Analytik Jena AG, Jena, Germany) at 0.2 mM Fe according 
to the manufacturer’s instructions. The results were compared 
and visualized using GraphPad Prism 5.0 Mac (GraphPad 
Prism Software).
OcT imaging
OCT imaging was performed using a Dragonfly™ optical 
catheter (St Jude Medical, Inc., Little Canada, MN, USA) 
connected to an OPTIS™ OCT imaging system (St Jude 
Medical, Inc.) according to the manufacturer’s instructions. 
Sixteen OCT imaging pullbacks were done of phantom pairs 
with different combinations of macrophages loaded with 
VSOP 1 and VSOP 2, ferumoxytol or empty cells as control 
and of VSOP and ferumoxytol in suspension. The cell phan-
toms were analyzed for the signal backscatter and attenuation 
values using the Tissue Properties tool of the ILUMIEN™ 
OPTIS™ Offline Review Workstation (Tissue Properties 
Supplement; St Jude Medical, Inc.). From each cell phan-
tom, five sections were analyzed by half automatic selection 
of an ROI around the cells and measuring attenuation and 
backscatter values with Tissue Properties tool (Figure S1). 
ROI parts with diminishing signal in the periphery below the 
software’s threshold were excluded by the software. The stock 
solution phantoms of 10 µL VSOP and 10 µL ferumoxytol 
(both 0.5 M Fe) did not generate sufficient signal to select and 
analyze ROIs with the Tissue Properties tool. The values were 
averaged, and the results were displayed and analyzed employ-
ing a one-way ANOVA with Tukey’s multiple comparison test 
of GraphPad Prism 5.0 Mac (GraphPad Prism Software).
Results
labeling of macrophages with iron 
oxide NPs
By exploiting the inherent contrast, the exemplary, unstained 
TEM image of Figure 1 visualizes the typical intracellular 
uptake of VSOP into macrophages of atherosclerotic plaques 
after intravenous application. The micrograph demonstrates 
representatively the formation of NP clusters in phago-
lysosomes. The uptake of iron oxide NPs by RAW 264.7 
0.2 µm
Figure 1 TeM of VsOP in atherosclerotic plaques.
Notes: after intravenous injection, VsOP accumulate in atherosclerotic plaques 
of apoe-/- mice as aggregates in phagolysosomal structures of macrophages as 
shown here, as well as in endothelial cells (not shown).7 The small iron oxide cores 
themselves provide the native contrast for TeM of unstained tissue sections and are 
separately distinguishable.
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macrophages were visualized by Prussian blue iron staining 
(Figure 2). Incubations with 1 mM Fe VSOP (concentration 1) 
and 2 mM Fe VSOP (concentration 2) were more effective 
than incubation with 8.9 mM Fe ferumoxytol and resulted 
in NP uptakes of 7.1±1.5, 12±1.5 and 6.6±2 pg Fe per cell, 
respectively. Cell phantoms loaded with iron oxide particles 
as measured by OCT were brown in contrast to the white color 
of the control cells.
light scattering by spectroscopy
NPs (VSOP and ferumoxytol) in suspension did not show sig-
nificant light scattering, especially in the near-infrared range 
(700–900 nm wavelength), when measured by spectropho-
tometry (Figure 3). However, when similar amounts of NPs 
were taken up by the macrophages, VSOP and ferumoxytol 
increased the scattering of these cells substantially: the scat-
tering signal of VSOP-labeled macrophages with 7.1±1.5 
pg Fe per cell (VSOP 1) and 12±1.5 pg Fe per cell (VSOP 
2) at 700 nm was 2.4-fold (214 arbitrary units [AU]) and 
3.6-fold (322 AU) higher than that of unlabeled macrophages 
(90 AU; Figure 3) and .100-fold higher than the scattering 
produced by VSOP in suspension (1.82 AU) at a comparable 
concentration (Figure 3A, C and E). But on incubation with 
ferumoxytol at a higher concentration (8.9 mM Fe), the 
cellular uptake of ferumoxytol was lower (6.6±2 pg Fe per 
cell) and it caused a scattering signal of 129.8 AU at 700 nm, 
representing a 1.4-fold increase compared to unlabeled mac-
rophages (Figure 3B, D and F). Conversely, at wavelengths 
below 400 nm, the scattering signal of NP-labeled cells was 
lower than the scattering of unlabeled cells, which fits to the 
high absorption of NP in suspension in the ultraviolet range 
that becomes negligible in the near-infrared spectrum, that 
is, above 700 nm.
OcT imaging
In accordance with the spectroscopy measurements, Figure 4 
shows that cell phantoms of macrophages that took up NP had 
a higher backscattering signal and a substantially higher atten-
uation in OCT imaging compared to unlabeled macrophages. 
The increase in backscattering signals was significantly higher 
for cells labeled with VSOP concentration 1 (5.82±0.27 AU; 
P,0.001) and VSOP 2 (6.07±0.12 AU; P,0.001) in com-
parison to control cells (5.49±0.12 AU), whereas ferumoxytol 
that is less effectively taken up by the macrophages did not 
cause a significant increase of scattering (5.68±0.22 AU; ns), 
as shown in Figure 5A. In contrast, the increase in signal 
Figure 2 cell phantoms of macrophages labeled with NPs as measured with OcT and Prussian blue iron staining.
Notes: White cell pellets correspond to non-labeled raW 264.7 macrophages (A) in comparison to brown cells pellets after NP uptake on incubation of macrophages 
with (B) 1 mM Fe VsOP, (C) 2 mM Fe VsOP and (D) 8.9 mM Fe ferumoxytol. all cells show intracellular NP uptake (B–D) and preserved cell morphology and viability in 
comparison with non-labeled cells (A). all scale bars correspond to 50 µm.
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Figure 3 spectroscopic analysis: light scattering of NP-loaded cells, control cells (raW 264.7 macrophage cell line) and NP in suspension, depending on the wavelength.
Notes: VsOP (left) and ferumoxytol (right) in suspension demonstrate only minimal light scattering (A, B) (red lines), especially above 600 nm (C, D is an enlargement of 
A, B). The control macrophages scatter especially below 450 nm (dotted black lines). suspensions of NP-loaded cells (calculated concentrations for 2×106 cells per 500 µl 
for VsOP 1 7.1±1.5 pg Fe/cell; VsOP 2 12±1.5 pg Fe/cell; ferumoxytol 6.6±2 pg Fe/cell) in final iron concentrations comparable to the NP suspensions increase the scattered 
light substantially, especially at wavelengths above 450 nm, including the near-infrared region (.700 nm; C, D). The absorption spectra of the NPs in suspension are given in 
panels (E) and (F) (red lines), running inversely to the light scattering ratio of NP-loaded vs unloaded macrophages (black lines). The high light absorption of the NP in the 
UV range might explain the lower scattering signal of the NP-loaded macrophages below 400 nm wavelength.
Abbreviations: aU, arbitrary units; NP, nanoparticle; UV, ultraviolet; VsOP, very small iron oxide particles.
attenuation was significant for all cell phantoms with NP 
uptake (control cells: 3.12±0.42 AU; VSOP 1: 5.30±0.32 AU; 
VSOP 2: 6.63±0.43 AU; ferumoxytol: 4.56±0.13 AU; all 
P,0.001; Figure 5B).
As for the spectroscopy measurements, stock solutions 
of NP in suspension (both ~0.5 M Fe) did not cause any 
relevant OCT signal despite higher NP concentrations, 
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was so low that the half automatic selection of a measure-
ment ROI with the Tissue Property tool was not possible, 
and thus, no attenuation or backscattering values for the 
NP suspension phantoms could be determined with the 
software.
Discussion
In the present study, we demonstrated that iron oxide NPs 
(VSOP and ferumoxytol) in suspension cause neither relevant 
backscattering in spectroscopy in the wavelength range 








Figure 4 OcT images of iron oxide NP-labeled macrophages.
Notes: Unlabeled raW 264.7 cell phantoms (A), labeled with VsOP at concentration 2 (12±1.5 pg Fe/cell) (B), labeled with VsOP at concentration 1 (7.1±1.5 pg Fe/cell) 
(C) and labeled with ferumoxytol (6.6±2 pg Fe/cell) (D). In comparison to the unlabeled cells, NP labeling increased the OcT signal of macrophages and induced stronger 
attenuation. In contrast, VsOP (E) and ferumoxytol (F) in suspension (no cells) with slightly higher NP concentrations than the cell phantoms did not generate visible OcT 
signals, which is in accordance to the spectroscopy measurements (Figure 3).
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Figure 5 analysis of OcT signals of raW 264.7 cell phantoms.
Notes: ***P,0.01. averaged OcT signal backscatter (A) and signal attenuation (B) of cell phantoms (Figure 4) from seven pullback measurements and five sections each. 
The NP suspensions of VSOP and ferumoxytol (without cells) did not generate sufficient OCT signal to be analyzed by the OCT software tool. NP uptake in the macrophages 
resulted in higher OCT backscattering signals (significant for VSOP concentration 1 and 2, P,0.01) and strong signal attenuation of the cell phantoms (significant for VSOP 
and ferumoxytol, P,0.01). statistical analysis: one-way aNOVa with Tukey’s multiple comparison test using graphPad Prism 5.0 Mac (graphPad Prism software).
Abbreviations: aU, arbitrary units; NP, nanoparticle; OcT, optical coherence tomography; VsOP, very small iron oxide particles.
substantially increased the backscattering in spectroscopy 
and backscattering as well as attenuation in OCT imaging 
when taken up by macrophages. This effect could be related 
to the clustering of the NPs once they are taken up into phago-
lysosomes of the macrophages (Figure 1).7,9,10 An explana-
tion could be that when the NP size is substantially smaller 
(VSOP ~8 nm, ferumoxytol 17–31 nm) than the wavelength 
of light (OCT wavelength around 1,000 nm), the intensity of 
the light scattering is proportional to the sixth power of par-
ticle size (Rayleigh theory).11 NP uptake into phagolysosomes 
of macrophages results in NP aggregates that can serve as 
substantially enlarged scatterers compared to the individual 
NPs in suspension, thereby increasing light backscattering 
and attenuation as seen in spectroscopic light scattering mea-
surements and OCT imaging. The NP uptake of the cells in 
this study was relatively high, but we have shown ex vivo by 
quantitative laser ablation inductively coupled plasma mass 
spectrometry in a previous study that VSOP do accumulate 
in atherosclerotic plaques in very high local concentrations 
(eg, local tissue particle concentrations of 50 mM Fe).12
Importantly, the OCT measurements were done with an 
OCT system and settings as used in the clinics. Considering 
the strongest increase of the backscattering signal at ~600 nm 
for VSOP that is below the wavelength range of the OCT 
system, the OCT sensitivity for NPs could potentially even 
be improved by modifications of the OCT system and mea-
surement protocols to exploit these properties.
It is important to highlight that macrophages are already 
distinguishable in OCT imaging by their pronounced attenu-
ation and backscattering in comparison to the other constitu-
ents of atherosclerotic plaques, even though it is difficult.13 
Thus, the higher attenuation and backscattering caused by 
NP uptake by the macrophages is in addition to the intrinsic 
higher OCT signal of these cells and could, therefore, sub-
stantially improve their identification in vivo by OCT.
limitations
The OCT images of the cell pellets might appear somewhat 
noisy because the cell pellets do not have structures like arte-
rial walls have and the cell pellets are, in general, very densely 
packed, explaining that no individual cells are discernible. 
Another important aspect to consider is the necessity for the 
OCT light to penetrate several optical boundaries (catheter/
air/plastic/cell pellet) that are less and different in vivo 
(catheter/blood/vessel wall). Certainly, the in vitro results 
need to be confirmed by future in vivo studies with animals 
that allow OCT imaging.
Moreover, the OCT system was an unmodified clinical 
device. Due to the distinct optical properties of macrophages 
after NP uptake (see Light scattering by spectroscopy sec-
tion), future modifications of the OCT system, imaging 
procedure and post-processing have a great potential to 
further enhance detection of the NP-loaded cells.
Conclusion
In this in vitro study, we demonstrated that small NPs sig-
nificantly increase the backscattering and OCT signal of 
macrophages, once they are taken up and cluster in phago-
lysosomes. Previous in vivo studies have shown that these 
NPs are taken up by plaque macrophages and allow effec-
tive MR imaging of atherosclerotic plaques. Therefore, we 
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in atherosclerotic plaques could be substantially improved 
by NP-enhanced OCT imaging of macrophages.
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Figure S1 Example for quantification of the OCT images with the ILUMIENTM OPTISTM Offline Review Workstation Tissue Properties Supplement.
Notes: The rOIs were drawn in the region of the macrophage cells in the reaction tubes in a semi-automatic way by selecting rOIs beginning at the bottom of the 
macrophage cell pellets. The software reduced the rOI at the distant side when reaching a lower signal threshold. The values of attenuation and Backscatter (rOI line) were 
used and averaged from five sections of each pellet of the OCT pullbacks.
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